Anti Cardiolipin – IgG at Dr. Essa Lab

Anti Cardiolipin – IgG at Dr. Essa Lab

The Anti Cardiolipin – IgG test is a specialized immunological assay performed to detect the presence of IgG-class autoantibodies directed against cardiolipin, a key phospholipid component of the inner mitochondrial membrane and cellular membranes. At Dr. Essa Laboratory & Diagnostic Centre, this test is executed using state-of-the-art automated immunoassay platforms, ensuring the highest standards of analytical precision and clinical reliability. Cardiolipin antibodies are closely associated with an increased tendency to develop abnormal blood clots (thrombosis) and are a primary diagnostic marker for Antiphospholipid Syndrome (APS), also known as Hughes Syndrome. Understanding the presence and concentration of these autoantibodies is critical for clinicians managing complex hematological, rheumatological, and obstetric conditions.

The physiological mechanism of Anti Cardiolipin – IgG involves the immune system mistakenly identifying cardiolipin as a foreign threat, producing immunoglobulins that bind to these phospholipids. This binding process, often mediated by a co-factor protein called beta-2-glycoprotein I, triggers a cascade of pro-thrombotic events. It activates platelets, endothelial cells, and monocytes, leading to a hypercoagulable state where blood clots form easily within both arteries and veins. By measuring the IgG isotype specifically, pathologists at Dr. Essa Lab provide clinicians with highly specific prognostic data, as IgG antibodies are generally considered more clinically significant and more strongly correlated with thrombotic events and pregnancy complications than IgM or IgA isotypes.

The clinical value of this test is immense. It serves as a cornerstone in the diagnostic workup for patients presenting with unexplained venous thromboembolism (such as deep vein thrombosis or pulmonary embolism), premature arterial thrombosis (such as stroke or myocardial infarction in young adults), and recurrent pregnancy losses. By identifying these autoantibodies, healthcare providers can initiate targeted therapeutic interventions, such as long-term anticoagulation or antiplatelet therapy, to mitigate the risk of life-threatening thrombotic events. Furthermore, in pregnant women with a history of recurrent miscarriages, a positive Anti Cardiolipin – IgG result guides obstetricians in implementing preventative protocols, including low-molecular-weight heparin (LMWH) and low-dose aspirin, significantly improving live birth rates.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the utmost accuracy of the Anti Cardiolipin – IgG test at Dr. Essa Lab, patients are advised to follow specific preparation guidelines. While strict fasting is generally not required for this immunological assay, maintaining optimal hydration by drinking plenty of water is highly recommended to facilitate a smooth venipuncture process. It is crucial for patients to inform their prescribing physician and the laboratory staff of all current medications, particularly anticoagulants (such as warfarin, heparin, or direct oral anticoagulants), antiplatelet drugs (like aspirin), and immunosuppressive therapies, as these can influence clinical management and the interpretation of the overall coagulation profile.

• Medication Disclosure: Provide a complete list of all prescription and over-the-counter medications to the lab technician.
• Hydration: Drink adequate amounts of water prior to sample collection to ensure veins are well-hydrated.
• No Fasting Required: You may eat and drink normally unless instructed otherwise for concurrent tests.
• Timing: It is often recommended to have the blood drawn during morning hours, though it can be performed at any time during laboratory operating hours.

During the Procedure

The sample collection process at Dr. Essa Lab is conducted by highly trained phlebotomists adhering to strict international standards of hygiene and patient safety. The procedure begins with the patient being comfortably seated. The phlebotomist identifies a suitable vein, typically in the antecubital fossa of the arm. The area is thoroughly sanitized with an antiseptic swab to prevent any contamination. A sterile, single-use needle is then inserted into the vein to collect a blood sample into a serum separator tube (SST) or a standard red-top tube.

The entire venipuncture process is completed within a few minutes and involves minimal discomfort, often described as a brief pinching sensation. Once the required volume of blood is collected, the needle is gently withdrawn, and immediate pressure is applied to the puncture site with a sterile cotton ball, followed by the application of a bandage to prevent bruising. The collected blood sample is then centrifuged to separate the serum from the cellular components. The serum is analyzed using advanced Enzyme-Linked Immunosorbent Assay (ELISA) or Chemiluminescent Immunoassay (CLIA) technology, which quantifies the concentration of IgG cardiolipin antibodies in GPL units.

When is an Anti Cardiolipin – IgG Performed?

Investigation of Unexplained Blood Clots (Thrombosis)

Physicians frequently request the Anti Cardiolipin – IgG test when a patient presents with unexplained or recurrent blood clots in either veins or arteries. This includes deep vein thrombosis (DVT) in the lower extremities, pulmonary embolism (PE) in the lungs, or arterial occlusions leading to stroke or transient ischemic attack (TIA) at an unusually young age (typically under 50 years). Identifying the presence of these autoantibodies helps determine if an underlying autoimmune hypercoagulable state is the primary driver of the thrombotic events, allowing for appropriate long-term anticoagulation planning.

Evaluation of Recurrent Pregnancy Loss

Recurrent pregnancy loss, defined as three or more consecutive unexplained spontaneous abortions before the 10th week of gestation, or one or more unexplained deaths of a morphologically normal fetus at or beyond the 10th week, is a major clinical indication for this test. Anti-cardiolipin antibodies can cause placental insufficiency, thrombosis of placental vessels, and localized inflammation, leading to fetal demise. Performing this test allows obstetricians to diagnose obstetric antiphospholipid syndrome and implement life-saving therapies in subsequent pregnancies.

Diagnosis of Antiphospholipid Syndrome (APS)

The Anti Cardiolipin – IgG test is one of the laboratory criteria required for the formal diagnosis of Antiphospholipid Syndrome (APS), alongside the Lupus Anticoagulant and Anti-Beta-2 Glycoprotein I tests. According to international consensus guidelines (Sapporo criteria), a diagnosis of APS requires at least one clinical criterion (vascular thrombosis or pregnancy morbidity) and at least one laboratory criterion (persistent positivity of antiphospholipid antibodies confirmed at least 12 weeks apart). This test is essential to establish this clinical diagnosis.

Monitoring Systemic Lupus Erythematosus (SLE)

Patients diagnosed with Systemic Lupus Erythematosus (SLE) or other systemic autoimmune connective tissue disorders are frequently screened for Anti Cardiolipin – IgG. Approximately 30% to 40% of patients with SLE also possess antiphospholipid antibodies, a condition referred to as secondary Antiphospholipid Syndrome. Monitoring these levels helps rheumatologists assess the patient’s overall risk for cardiovascular complications, renal vascular thrombosis, and neuropsychiatric manifestations, enabling proactive preventive care.

Investigating Unexplained Thrombocytopenia

Unexplained thrombocytopenia (a abnormally low platelet count) can be a clinical manifestation of Antiphospholipid Syndrome. The autoantibodies can bind to platelets, leading to their premature clearance by the spleen or consumption in subclinical microvascular clots. When a patient presents with persistent low platelets without an obvious cause, hematologists utilize the Anti Cardiolipin – IgG test to rule out an autoimmune-mediated destruction pathway associated with antiphospholipid antibodies.

What Does an Anti Cardiolipin – IgG Detect?

The Anti Cardiolipin – IgG test is highly sensitive and detects several key immunological and clinical parameters, including:

• Presence of IgG Autoantibodies: Confirms whether the immune system has produced IgG-class immunoglobulins targeting cardiolipin.
• Quantitative Antibody Concentration: Measures the exact concentration of antibodies in GPL units (G-phospholipid units).
• Low-Level Positivity: Identifies borderline or low-positive titers (typically 10 to 40 GPL) which may be transient or clinically less significant.
• High-Level Positivity: Detects strongly positive titers (typically greater than 40 GPL), which carry a high correlation with clinical thrombosis.
• Persistent Autoimmunity: When repeated after 12 weeks, confirms the persistent presence of antibodies, ruling out transient spikes due to infections.
• Risk of Venous Thromboembolism: Assesses the likelihood of deep vein thrombosis and pulmonary embolism.
• Risk of Arterial Thrombosis: Indicates elevated risk for ischemic stroke, myocardial infarction, and peripheral arterial occlusion.
• Obstetric Complications Risk: Evaluates the risk of placental infarction, preeclampsia, intrauterine growth restriction (IUGR), and stillbirth.
• Secondary Antiphospholipid Syndrome: Detects associated autoimmune activity in patients already diagnosed with Systemic Lupus Erythematosus (SLE).
• Primary Antiphospholipid Syndrome: Helps identify APS in patients with no other underlying autoimmune disorders.
• Livedo Reticularis Association: Correlates with specific dermatological findings like a purplish, lace-like discoloration of the skin.
• Neurological Risk Factors: Assesses risk for non-stroke neurological manifestations such as chorea, transverse myelitis, or cognitive decline associated with APS.
• Renal Microangiopathy Risk: Evaluates potential for small blood clots in the kidneys, which can impair renal function.
• Valvular Heart Disease Association: Identifies patients at risk for cardiac valve thickening or vegetations (Libman-Sacks endocarditis).
• Transient Positivity from Infections: Helps differentiate transient positive results caused by acute infections (such as syphilis, malaria, hepatitis, or HIV) from chronic autoimmune conditions.
• Drug-Induced Antibody Production: Detects antibodies that may have been induced by certain medications, including chlorpromazine, procainamide, or phenytoin.
• Co-factor Dependency: Indirectly indicates the presence of antibodies that require beta-2-glycoprotein I for binding, which are highly pathogenic.
• Thrombocytopenia Correlation: Assists in explaining the underlying cause of moderate to severe platelet deficiency.
• Prophylactic Treatment Guidance: Provides objective data to justify the initiation of prophylactic aspirin or heparin therapy.
• Therapeutic Monitoring: Helps clinicians evaluate the baseline antibody burden before initiating long-term anticoagulation management.

Turnaround Time and Report Access at Dr. Essa Lab

Dr. Essa Laboratory & Diagnostic Centre is renowned for its efficient operational workflow and rapid reporting systems. For specialized immunological assays such as the Anti Cardiolipin – IgG test, the standard turnaround time is typically within 24 to 48 hours from the time of sample collection. Because this test requires precise automated ELISA or CLIA processing, quality control protocols are strictly enforced at every step to guarantee the clinical accuracy of the final report.

Patients can access their diagnostic reports conveniently through multiple digital channels. Once the results are verified by a consultant pathologist, an automated SMS notification containing a direct secure link is sent to the patient’s registered mobile number. Reports can also be viewed, downloaded, and printed directly from the official Dr. Essa Lab website by entering the patient’s lab ID and password. For those who prefer physical copies, reports can be collected from any of the numerous Dr. Essa Lab collection centers located across Karachi and other major cities.

Anti Cardiolipin – IgG Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
IgG Antibody Level (GPL)	Negative (< 10 GPL units)	Positive (> 10 GPL units); Strong Positive (> 40 GPL units)
Clinical Interpretation	No detectable cardiolipin IgG autoantibodies	Presence of cardiolipin IgG autoantibodies, indicating potential APS
Thrombotic Risk Profile	Standard baseline population risk	Significantly elevated risk for venous and arterial thrombosis
Pregnancy Risk Profile	Normal pregnancy progression expected	Increased risk of recurrent miscarriage, preeclampsia, and IUGR
Persistence (at 12 weeks)	Not applicable (Negative)	Persistent positive results confirm chronic autoimmune APS
Platelet Count Correlation	Normal platelet count (150,000 – 450,000/µL)	Thrombocytopenia (low platelets) associated with antibody activity
Co-factor Association	No beta-2-glycoprotein I binding activity	Strong binding activity, indicating highly pathogenic antibodies

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Anti Cardiolipin – IgG?

• Pathology Expertise: Led by highly qualified, experienced consultant pathologists who ensure rigorous clinical standards.
• ISO Certified Quality: Dr. Essa Lab maintains international quality standards, including ISO 9001 and ISO 15189 certifications.
• Advanced Technology: Utilizes fully automated ELISA and CLIA analyzers for precise quantification of autoantibodies.
• Extensive Network: Conveniently located collection centers across Karachi and Pakistan, making diagnostic services highly accessible.
• Online Report Portal: Secure, 24/7 digital access to download and share laboratory reports from the comfort of your home.
• Home Sample Collection: Reliable and professional home blood collection services available throughout major cities.
• Legacy of Trust: Over three decades of dedicated service in diagnostic medicine, established in 1987.
• Comprehensive Testing Panels: Offers complete antiphospholipid panels, including Lupus Anticoagulant and Anti-Beta-2 Glycoprotein I, for thorough diagnostic evaluation.